Retinal transcriptome analysis in db/db mice after sodium-glucose cotransporter 2 inhibitor application

被引：0
|
作者：
Ahn, Jeeyun [1 ,2 ]
Shin, Jooyoung [1 ,2 ]
Park, Junghyun [3 ]
Moon, Min Kyong [4 ,5 ]
机构：
[1] Seoul Natl Univ, Coll Med, Dept Ophthalmol, Seoul, South Korea
[2] Seoul Natl Univ, Seoul Metropolitan Govt, Boramae Med Ctr, Dept Ophthalmol, Seoul, South Korea
[3] Inje Univ, Seoul Paik Hosp, Dept Ophthalmol, Gimhae, South Korea
[4] Seoul Natl Univ, Coll Med, Dept Internal Med, Seoul, South Korea
[5] Seoul Natl Univ, Seoul Metropolitan Govt, Boramae Med Ctr, Dept Internal Med, Seoul, South Korea
来源：
INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE | 2019年 / 60卷 / 09期
关键词：
D O I：
暂无
中图分类号：
R77 [眼科学];
学科分类号：
100212 ;
摘要：
5367
引用
收藏
页数：2
相关论文
共 50 条
  • [21] Sodium-Glucose Cotransporter 2 Inhibitors
    Erol, Cetin
    ANATOLIAN JOURNAL OF CARDIOLOGY, 2024, 28 (05): : 216 - 216
  • [22] Inhibition of sodium-glucose cotransporter 2
    Martin, S.
    DIABETOLOGE, 2013, 9 (04): : 289 - +
  • [23] Sodium-glucose cotransporter-2 inhibitor-associated thrombocytopenia
    Bando, Hironori
    Hirota, Yushi
    Ogawa, Wataru
    HORMONES-INTERNATIONAL JOURNAL OF ENDOCRINOLOGY AND METABOLISM, 2025, 24 (01): : 165 - 166
  • [24] Ipragliflozin: A novel sodium-glucose cotransporter 2 inhibitor developed in Japan
    Ohkura, Tsuyoshi
    WORLD JOURNAL OF DIABETES, 2015, 6 (01) : 136 - 144
  • [25] Sodium Glucose Transporter Type 2 (SGLT2) Inhibitor, Empagliflozin, Improves Diastolic Function in Female Diabetic db/db Mice
    Demarco, Vincent G.
    Aroor, Annayya R.
    Nistala, Ravi
    Garro, Mona
    Mayoux, Eric W.
    Whaley-Connell, Adam
    Sowers, James R.
    DIABETES, 2015, 64 : A552 - A552
  • [26] Sodium-glucose cotransporter 2 inhibitor Dapagliflozin attenuates diabetic cardiomyopathy
    Arow, M.
    Waldman, M.
    Yadin, D.
    Nudelman, V.
    Shainberg, A.
    Abraham, N. G.
    Freimark, D.
    Kornowski, R.
    Aravot, D.
    Hochhauser, E.
    Arad, M.
    CARDIOVASCULAR DIABETOLOGY, 2020, 19 (01)
  • [27] Canagliflozin, a new sodium-glucose cotransporter 2 inhibitor, in the treatment of diabetes
    Nisly, Sarah A.
    Kolanczyk, Denise M.
    Walton, Alison M.
    AMERICAN JOURNAL OF HEALTH-SYSTEM PHARMACY, 2013, 70 (04) : 311 - 319
  • [28] Energy Balance After Sodium-Glucose Cotransporter 2 Inhibition
    Ferrannini, Giulia
    Hach, Thomas
    Crowe, Susanne
    Sanghvi, Arjun
    Hall, Kevin D.
    Ferrannini, Ele
    DIABETES CARE, 2015, 38 (09) : 1730 - 1735
  • [29] Empagliflozin: A sodium-glucose cotransporter 2 inhibitor for treatment of type 2 diabetes
    Dixit, Divisha
    Yoon, Youngmin
    Volino, Lucio R.
    Mansukhani, Rupal Patel
    AMERICAN JOURNAL OF HEALTH-SYSTEM PHARMACY, 2015, 72 (22) : 1943 - 1954
  • [30] Ipragliflozin, a sodium-glucose cotransporter 2 inhibitor, in the treatment of type 2 diabetes
    Hedrington, Maka S.
    Davis, Stephen N.
    EXPERT OPINION ON DRUG METABOLISM & TOXICOLOGY, 2015, 11 (04) : 613 - 623
12345